165 related articles for article (PubMed ID: 15108247)
1. Pregnancy outcomes following systemic prenatal acyclovir exposure: Conclusions from the international acyclovir pregnancy registry, 1984-1999.
Stone KM; Reiff-Eldridge R; White AD; Cordero JF; Brown Z; Alexander ER; Andrews EB
Birth Defects Res A Clin Mol Teratol; 2004 Apr; 70(4):201-7. PubMed ID: 15108247
[TBL] [Abstract][Full Text] [Related]
2. Acyclovir in pregnancy registry: six years' experience. The Acyclovir in Pregnancy Registry Advisory Committee.
Andrews EB; Yankaskas BC; Cordero JF; Schoeffler K; Hampp S
Obstet Gynecol; 1992 Jan; 79(1):7-13. PubMed ID: 1727590
[TBL] [Abstract][Full Text] [Related]
3. Pregnancy outcomes following systemic prenatal acyclovir exposure--June 1, 1984-June 30, 1993.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 1993 Oct; 42(41):806-9. PubMed ID: 8413168
[TBL] [Abstract][Full Text] [Related]
4. Assessing the risk of birth defects associated with antiretroviral exposure during pregnancy.
Watts DH; Covington DL; Beckerman K; Garcia P; Scheuerle A; Dominguez K; Ross B; Sacks S; Chavers S; Tilson H
Am J Obstet Gynecol; 2004 Sep; 191(3):985-92. PubMed ID: 15467577
[TBL] [Abstract][Full Text] [Related]
5. Risk of birth defects associated with nelfinavir exposure during pregnancy.
Covington DL; Conner SD; Doi PA; Swinson J; Daniels EM
Obstet Gynecol; 2004 Jun; 103(6):1181-9. PubMed ID: 15172850
[TBL] [Abstract][Full Text] [Related]
6. Use of acyclovir, valacyclovir, and famciclovir in the first trimester of pregnancy and the risk of birth defects.
Pasternak B; Hviid A
JAMA; 2010 Aug; 304(8):859-66. PubMed ID: 20736469
[TBL] [Abstract][Full Text] [Related]
7. First-trimester exposure to alprazolam.
St Clair SM; Schirmer RG
Obstet Gynecol; 1992 Nov; 80(5):843-6. PubMed ID: 1407925
[TBL] [Abstract][Full Text] [Related]
8. Outcomes of congenital diaphragmatic hernia: a population-based study in Western Australia.
Colvin J; Bower C; Dickinson JE; Sokol J
Pediatrics; 2005 Sep; 116(3):e356-63. PubMed ID: 16140678
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of selected characteristics of pregnancy drug registries.
Honein MA; Paulozzi LJ; Cragan JD; Correa A
Teratology; 1999 Dec; 60(6):356-64. PubMed ID: 10590397
[TBL] [Abstract][Full Text] [Related]
10. Birth outcome in women treated with azathioprine or mercaptopurine during pregnancy: A Danish nationwide cohort study.
Langagergaard V; Pedersen L; Gislum M; Nørgard B; Sørensen HT
Aliment Pharmacol Ther; 2007 Jan; 25(1):73-81. PubMed ID: 17229222
[TBL] [Abstract][Full Text] [Related]
11. Varicella vaccine exposure during pregnancy: data from 10 Years of the pregnancy registry.
Wilson E; Goss MA; Marin M; Shields KE; Seward JF; Rasmussen SA; Sharrar RG
J Infect Dis; 2008 Mar; 197 Suppl 2():S178-84. PubMed ID: 18419394
[TBL] [Abstract][Full Text] [Related]
12. Use of the combined first-trimester screen result and low PAPP-A to predict risk of adverse fetal outcomes.
Barrett SL; Bower C; Hadlow NC
Prenat Diagn; 2008 Jan; 28(1):28-35. PubMed ID: 18186146
[TBL] [Abstract][Full Text] [Related]
13. Lamotrigine and the risk of malformations in pregnancy.
Cunnington M; Tennis P;
Neurology; 2005 Mar; 64(6):955-60. PubMed ID: 15781807
[TBL] [Abstract][Full Text] [Related]
14. Report from the National Transplantation Pregnancy Registry: outcomes of pregnancy after transplantation.
Armenti VT; Daller JA; Constantinescu S; Silva P; Radomski JS; Moritz MJ; Gaughan WJ; McGrory CH; Coscia LA
Clin Transpl; 2006; ():57-70. PubMed ID: 18368705
[TBL] [Abstract][Full Text] [Related]
15. Outcomes of pregnancies following a birth with major birth defects: a population based study.
Melve KK; Skjaerven R
Early Hum Dev; 2008 Oct; 84(10):651-7. PubMed ID: 18514444
[TBL] [Abstract][Full Text] [Related]
16. Final results from the 16-year sumatriptan, naratriptan, and treximet pregnancy registry.
Ephross SA; Sinclair SM
Headache; 2014; 54(7):1158-72. PubMed ID: 24805878
[TBL] [Abstract][Full Text] [Related]
17. Continued occurrence of Accutane-exposed pregnancies.
Honein MA; Paulozzi LJ; Erickson JD
Teratology; 2001 Sep; 64(3):142-7. PubMed ID: 11514944
[TBL] [Abstract][Full Text] [Related]
18. Pregnancy outcomes after maternal exposure to simvastatin and lovastatin.
Pollack PS; Shields KE; Burnett DM; Osborne MJ; Cunningham ML; Stepanavage ME
Birth Defects Res A Clin Mol Teratol; 2005 Nov; 73(11):888-96. PubMed ID: 16163683
[TBL] [Abstract][Full Text] [Related]
19. First trimester predictors of adverse pregnancy outcomes.
Brameld KJ; Dickinson JE; O'Leary P; Bower C; Goldblatt J; Hewitt B; Murch A; Stock R
Aust N Z J Obstet Gynaecol; 2008 Dec; 48(6):529-35. PubMed ID: 19133038
[TBL] [Abstract][Full Text] [Related]
20. Monitoring pregnancy outcomes after prenatal drug exposure through prospective pregnancy registries: a pharmaceutical company commitment.
Reiff-Eldridge R; Heffner CR; Ephross SA; Tennis PS; White AD; Andrews EB
Am J Obstet Gynecol; 2000 Jan; 182(1 Pt 1):159-63. PubMed ID: 10649172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
